Edwards Lifesciences (EW) Tops Q3 EPS by 9c, Q4 & FY Guidance Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Canaccord Genuity Reiterates Buy on Edwards Lifesciences (EW) following 3Q Results
October 27, 2015 10:50 AM EDTCanaccord Genuity reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), and raised the price target to $180.00 (from $178.00), following the company's 3Q earnings results. EW reported EPS of $1.07, beating consensus by 9c. Management does an excellent job hedging FX swings to neutralize EPS... More
UBS Raises Price Target on Edwards Lifesciences (EW) Following Strong 3Q Results
October 27, 2015 8:57 AM EDTUBS reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), and raised the price target to $203.00 (from $201.00), following the company's 3Q15 earnings results. Management upped fullyear EPS guidance by $4.43-4.53 from $4.30-4.40, which assumes a touch more upside in Q4.
Analyst Matt Miksic... More
